Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 2
2003 4
2004 2
2006 1
2008 1
2009 4
2010 2
2013 1
2014 5
2015 2
2019 1
2020 5
2021 4
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

33 results

Results by year

Filters applied: . Clear all
Page 1
The Role of Plasma Cells as a Marker of Chronic Endometritis: A Systematic Review and Meta-Analysis.
Santoro A, Travaglino A, Inzani F, Angelico G, Raffone A, Maruotti GM, Straccia P, Arciuolo D, Castri F, D'Alessandris N, Scaglione G, Valente M, Cianfrini F, Masciullo V, Zannoni GF. Santoro A, et al. Among authors: masciullo v. Biomedicines. 2023 Jun 15;11(6):1714. doi: 10.3390/biomedicines11061714. Biomedicines. 2023. PMID: 37371809 Free PMC article. Review.
Emerging drugs for endometrial cancer.
Amadio G, Masciullo V, Ferrandina MG, Scambia G. Amadio G, et al. Among authors: masciullo v. Expert Opin Emerg Drugs. 2014 Dec;19(4):497-509. doi: 10.1517/14728214.2014.971752. Epub 2014 Oct 21. Expert Opin Emerg Drugs. 2014. PMID: 25330855 Review.
An update on the pharmacotherapy for endometrial cancer.
Amadio G, Masciullo V, Stefano L, Scambia G. Amadio G, et al. Among authors: masciullo v. Expert Opin Pharmacother. 2013 Dec;14(18):2501-9. doi: 10.1517/14656566.2013.849241. Epub 2013 Oct 21. Expert Opin Pharmacother. 2013. PMID: 24138224 Review.
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence.
Mascilini F, Amadio G, Di Stefano MG, Ludovisi M, Di Legge A, Conte C, De Vincenzo R, Ricci C, Masciullo V, Salutari V, Scambia G, Ferrandina G. Mascilini F, et al. Among authors: masciullo v. Onco Targets Ther. 2014 Jul 12;7:1273-84. doi: 10.2147/OTT.S51550. eCollection 2014. Onco Targets Ther. 2014. PMID: 25050069 Free PMC article. Review.
Primary Mucinous Cystadenocarcinoma of the Breast Intermixed with Pleomorphic Invasive Lobular Carcinoma: The First Report of This Rare Association.
Vegni F, D'Alessandris N, Santoro A, Angelico G, Scaglione G, Carlino A, Arciuolo D, Valente M, Sfregola S, Natale M, Sanchez AM, Masciullo V, Zannoni GF, Mulè A. Vegni F, et al. Among authors: masciullo v. J Pers Med. 2023 Jun 3;13(6):948. doi: 10.3390/jpm13060948. J Pers Med. 2023. PMID: 37373937 Free PMC article.
The cl2/dro1/ccdc80 null mice develop thyroid and ovarian neoplasias.
Leone V, Ferraro A, Schepis F, Federico A, Sepe R, Arra C, Langella C, Palma G, De Lorenzo C, Troncone G, Masciullo V, Scambia G, Fusco A, Pallante P. Leone V, et al. Among authors: masciullo v. Cancer Lett. 2015 Feb 28;357(2):535-41. doi: 10.1016/j.canlet.2014.12.010. Epub 2014 Dec 9. Cancer Lett. 2015. PMID: 25497869
33 results